Equity Analysis /

Genomma Lab Internacional: Flash LAB: OTC plant may finally start up

  • Genomma Lab received the GMP Certification from COFEPRIS, after a long delay due to the pandemic

  • Lab could start up its OTC plant, with which the company may move forward in its vertical integration

  • Lab´s outlook is favorable as profitability improvements may be achieved gradually and revenue growth pace will resume

Juan Barbier
Juan Barbier

Equity Research Analyst

Marissa Garza Ostos
Marissa Garza Ostos

Head of Equity Research

7 September 2021
Published by